Organisation paid for research Program year 2025 Source: CMS Open Payments

Charleston Ent Associates LLC

Neither a doctor nor a teaching hospital

Research payments

$162,324

436 payments

Through program year 2025, Charleston Ent Associates LLC is reported as receiving $162,324 in research payments, across 436 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $94,388 136
2024 Research $63,940 297
2023 Research $3,996 3

Breakdown

Who paid Research payments · program years 2023–2025
  1. Regeneron Pharmaceuticals, Inc. $90,435 431 payments
  2. Paratek Pharmaceuticals, Inc. $71,889 5 payments
Studies the money was for Research payments · program years 2023–2025
  1. A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps $71,889 5 payments
  2. Assessing Long-Term Outcomes of DUPIXENT Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyposis (AROMA) $55,079 268 payments
  3. Registry of Asthma Patients Initiating DUPIXENT (RAPID) $35,356 163 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record